Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
Recruiting now
Conditions studied: Prostate Cancer
In brief
A multicentre observational study on treatment patterns and ctDNA HRR evaluation in aggressive high-volume metastatic hormone-sensitive prostate cancer in Russian Federation
Key facts
- Study ID
- NCT07052578
- Run by
- AstraZeneca
- People needed
- 400
- Starts
- 2025-06-30
- Expected to finish
- 2028-11-30
- Last updated by the study team
- 2026-07-10
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Male patients aged ≥ 18 years old;
- Signed ICF, including consent for blood samples ctDNA and ctDNA-based HRRm testing;
- Metastatic hormone-sensitive prostate cancer (mHSPC) (de novo or progressed from earlier stages);
- High-aggressive disease (Gleason 8-10);
- High-volume disease (according to CHAARTED trial criteria: presence of 4 and more (≥4) bone metastases (including at least one (≥1) outside the vertebral column/pelvis) and/or 1 and more (≥1) visceral metastasis);
- Availability of source medical documentation;
- Known HRRm status based on tumour sample evaluation performed in routine practice.
You may not qualify if…
- Participation in any interventional trial since the mPC diagnosis.
- Progression to mCRPC.
Where it is running
- Research Site — Arkhangelsk, Russia (enrolling)
- Research Site — Barnaul, Russia (enrolling)
- Research Site — Chelyabinsk, Russia (enrolling)
- Research Site — Irkutsk, Russia (enrolling)
- Research Site — Krasnodar, Russia (enrolling)
- Research Site — Krasnoyarsk, Russia (enrolling)
- Research Site — Moscow, Russia (enrolling)
- Research Site — Nal'chik, Russia (enrolling)
- Research Site — Nizhny Novgorod, Russia (enrolling)
- Research Site — Obninsk, Russia (enrolling)
- Research Site — Tomsk, Russia (enrolling)
- Research Site — Tyumen, Russia (enrolling)
- Research Site — Ufa, Russia (enrolling)
- Research Site — Yekaterinburg, Russia (enrolling)
- Research Site — Pskov, Russia
- Research Site — Saint Petersburg, Russia
- Research Site — Kazan', Russia
- Research Site — Saint Petersburg, Russia
- Research Site — Saransk, Russia
- Research Site — Sochi, Russia
- Research Site — Moscow, Russia
- Research Site — Moscow, Russia
- Research Site — Syktyvkar, Russia
- Research Site — Tomsk, Russia
- Research Site — Tver', Russia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.